Latest Spinogenix News & Updates

See the latest news and media coverage for Spinogenix. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Spinogenix

Synaptic regenerative therapeutics for brain disorders

spinogenix.com
Headquarters
Los Angeles, United States
Founded year
2016
Company type
Private company
Number of employees
4–10

Last updated

Latest news about Spinogenix

In short: Spinogenix advanced its synaptic regenerative pipeline, securing FDA Fast Track status and reported positive clinical results for ALS and Alzheimer's.

Company announcements

Spinogenix

Spinogenix founder speaks at symposium

Stella Sarraf shares her journey and Spinogenix's progress in synapse regeneration for ALS, Alzheimer’s, schizophrenia, and Fragile X, with positive trial readouts.

Spinogenix

Spinogenix announces CLARITY Phase 2b/3 trial

It will evaluate oral SPG601 in male Fragile X patients, assessing EEG biomarkers and cognitive outcomes across dose regimens.

Unlock all announcements with a

Media coverage

Yahoo Finance

Spinogenix Announces CLARITY: a Phase 2b/3 trial of SPG601 for the Treatment of Fragile X Syndrome

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, is initiating CLARITY, a Phase 2b/3...

Unlock all articles with a

Never miss news about Spinogenix

Track Spinogenix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.